Signature Equity Partners’s Guardant Health GH Stock Holding History

Signature Equity Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.25K	Buy	+35	New	+$3.81K	﹤0.01%	980

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Signature Equity Partners's GH Position: Q2 2026 in Review

Signature Equity Partners opened a new position in Guardant Health (GH) in Q2 2026: 35 shares worth $5.25K. The stake represents ﹤0.01% of the portfolio and ranks #980 among its holdings.

597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Signature Equity Partners held 35 shares of Guardant Health worth $5.25K as of Q2 2026.
Guardant Health was a new Signature Equity Partners position in Q2 2026.
Guardant Health made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #980 holding.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.